TNF-α-mediated cardiorenal injury after rhabdomyolysis in rats

American Journal of Physiology - Renal Physiology

Volumn 308, Issue 11, 2015, Pages F1259-F1267

  Homsi, Eduardo ^a   Andreazzi, Diego Duarte ^a   De Lopes Faria, Jose Butori ^a   Janino, Patrícia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Acute kidney injury; Apoptosis; Cardiac injury; Necroptosis; Rhabdomyolysis; Tumor necrosis factor

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CASPASE 3; CASPASE 8; CASPASE 9; CREATINE KINASE; CREATININE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GLYCEROL; INFLIXIMAB; NECROSTATIN 1; PROTEIN BAX; PROTEIN P53; PUMA PROTEIN; RECEPTOR BLOCKING AGENT; RECEPTOR INTERACTING PROTEIN 1; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CASPASE INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIORENAL SYNDROME; CELL DAMAGE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DOWN REGULATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HEART FUNCTION; INTRACELLULAR SIGNALING; KIDNEY FUNCTION; KIDNEY TUBULE NECROSIS; MALE; NECROPTOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHABDOMYOLYSIS; SINGLE DRUG DOSE; UPREGULATION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; METABOLISM; NECROSIS; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 8; CASPASE 9; CASPASE INHIBITORS; DISEASE MODELS, ANIMAL; MALE; NECROSIS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RHABDOMYOLYSIS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84930834848     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00311.2014     Document Type: Article

References (43)

1. Barbuio R, Milanski M, Bertolo M, Saad MJ, Velloso LA. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol 194: 539–550, 2007
2. El-Abdellati E, Eyselbergs M, Sirimsi H, Hoof VV, Wouters K, Verbrugghe W, Jorens PG. An observational study on rhabdomyolysis in the intensive care unit. Exploring its risk factors and main complication: acute kidney injury. Ann Intensive Care 3: 8–16, 2013
3. Fahling M, Mathia S, Paliege A, Koesters R, Mrowka R, Peters H, Persson PB, Neumayer HH, Bachmann SS, Rosenberger C. Tubular von Hippel-Lindau knockout protects against rhabdomyolysis-induced AKI. J Am Soc Neprol 24: 1806–1819, 2013
4. Felsenberg LR, Thevananther S, del Rio M, de Leon M, Derajavan P. Partial ATP depletion induces Fas-and caspase-mediated apoptosis in MDCK cells. Am J Physiol Renal Physiol 276: F837–F846, 1999
5. Grenz A, Kim JH, Bauerle JD, Tak E, Eltzschig HK, Clambey ET. Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNF-a release. J Immunol 189: 4566–4573, 2012
6. Han J, Zhong CQ, Zhang DW. Programmed necrosis: backup to and competitor with apoptosis in the immune system. Nat Immunol 12: 1143–1149, 2011
7. Homsi E, Janino P, de Faria JB. Role of caspases on cell death, inflammation and cell cycle in glycerol-induced acute renal failure. Kidney Int 69: 1385–1392, 2006
8. Homsi E, Silva SMS, Brito SM, Peixoto EBI, Lopes de Faria JB. p53-mediated oxidative stress and tubular injury in rats with glycerolinduced acute kidney injury. Am J Nephrol 33: 49–59, 2011
9. Hsu CH, Kurtz TW, Waldinger TP. Cardiac output and renal blood flow in glycerol-induced acute renal failure in the rat. Circ Res 40: 178–182, 1997
10. Huang X, Lu Z, Lv Z, Yu T, Yang P, Shen Y, Ding Y, Fu D, Zhang X, Yu Y. The FAS/FAS ligand death receptor pathway contributes to phenylalanine-induce apoptosis in cortical neurons. PLos One 8: e71553, 2013
11. Jia Z, Babu PV, Nallasamy P, Nallasami P, Zhu H, Misra HP, y LI, Liu D. Genistein inhibits TNF-a-induced endothelial inflammation through the protein kinase pathway A and improves vascular inflammation in C57BL/6 mice. Int J Cardiol 168: 2637–45, 2013
12. Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. J Am Soc Nephrol 14: 1549–1558, 2003
13. Kreuz S, Siegmund D, Scheurich P, Wajant H. NF-aB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21: 3964–3973, 2001
14. Li YF, Jeffrey PD, Yu JW, Shi Y. Cristal structure of a viral FLIP. Insights into FLIP-mediated inhibition of death receptor signaling. J Biol Chem 281: 2960–2968, 2006
15. Linkermann A, Green DR. Necroptosis. N Engl J Med 370: 455–465, 2014
16. Linkermann A, Bräsen JH, Darding M, Jin MK, Sanz AB, Heller JO, De Zen F, Weinlich R, Ortiz A, Walczak H, Weinberg JM, Green DR, Kunzendorf U, Krautwald S. Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci USA 110: 12024–12029, 2013
17. Linkermann A, Heller JO, Prókai A, Weinberg JM, De Zen F, Himmerkus N, Szabó AJ, Bräsen JH, Kunzendorf U, Krautwald S. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81: 751–761, 2012
18. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 23: 8576–8585, 2003
19. MacMahon GM, Zeng S, Wikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med 173: 1821–1828, 2013
20. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181–190, 2003
21. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 80: 293–299, 1995
22. Moore KP, Holt GS, Patel RP, Svistunenko DA, Zackert W, Goodier D, Reeder BJ, Clozel M, Anand R, Cooper CE, Morrow JD, Wilson MT, Darley-Usmar V, Roberts J. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 273: 31731–31737, 1998
23. Morgan MJ, Kim YS, Liu ZG. TNFa and reactive oxygen species in necrotic cell death. Cell Res 18: 343–349, 2008
24. Muret J, Hasmin M, Stsik I, Jalil A, Mallavialle A, Nanbakhsh A, Lacroix L, Billot K, Baud V, Thiery J, Vielh P, Terrier P, Wiels J, Vassilev L, Lecesne A, Bonvalot S, Chouaib S. Attenuation of soft tissue sarcomas resistance to the cytotoxic action of TNF-a by restoring p53 function. PLos One 7: e38808, 2012
25. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683–694, 2001
26. Oren M. Decision making of p53: life, death and cancer. Cell Death Differ 10: 431–442, 2003
27. Pastorino JG, Shulga N, Hoek JB. TNF-a-induced cell death in ethanolexposed cells depends on p38 MAPK signaling but is independent of Bid and caspase-8. Am J Physiol Gastrointest Liver Physiol 285: G503–G516, 2003
28. Sablina AA, Budanov AV, Ilyinskaya G, Agapova LS, Kravchenko JE, Chumavov PM. The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306–1313, 2005
29. Safa AR. C-FLIP, a master anti-apoptotic regulator. Exp Oncol 34: 176–184, 2012
30. Shahid M, Francis J, Majid DS. Tumor necrosis factor-a induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol 295: F1836–F1844, 2008
31. Shi Y, Nikulenkov F, Zawacka-Pankau J, Li H, Gabdoulline R, Xu J, Eriksoson S, Hesdstrom E, Issaeva N, Kel A, Arner ESJ, Selivanova G. ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis. Cell Death Differ 21: 612–623, 2014
32. Schmelz K, Wieder T, Tamm I, Muller A, Essmann F, Geilen CC, Schulze-Osthoff K, Dorken B, Daniel PT. Tumor necrosis factor _ sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-aB. Oncogene 23: 6743–6759, 2004
33. Shah SV, Walker PD. Evidence suggesting a role for hydroxyl radical in glycerol-induced acute renal failure. Am J Physiol Renal Fluid Electrolyte Physiol 255: F428–F433, 1988
34. Shulman LM, Yugas Y, Frolkis I, Gavendo S, Knetch A, Eliahou HE. Glycerol induced ARF in rats is mediated by tumor necrosis factor. Kidney Int 43: 1397–1401, 1993
35. Tang W, Chen Z, Wu W, Qiu H, Bo H, Zhang L, Fu P. Renal protective effect of early continuous venovenous hemofiltration in rhabdomyolysis: improved renal mitochondrial disfunction an inhibited apoptosis. Artif Organs 37: 390–400, 2013
36. Valesini G, Iannuccelli C, Marocchi E, Pascoli L, Scalzi V, Di Franco M. Biological and clinical effects of anti-TNFa treatment. Autoimmun Rev 7: 35–41, 2007
37. Vandenabeele P, Galluzzi L, Berghe TV, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700–714, 2010
38. Wang L, Du F, Wang X. TNF-a induces two distinct caspase-8 activation pathways. Cell 133: 693–703, 2008
39. Wolfert AI, Oken DE. Glomerular hemodynamics in established glycerol- induced acute renal failure in the rat. J Clin Invest 84: 1967–1973, 1989
40. Woodruff TM, Arumugam TV, Shiels Reid RC IA, Fairlie DP, Taylor SM. A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J Immunol 171: 5514–5520, 2003
41. Zager RA, Burkhart K. Myoglobin toxicity in proximal human kidney cells: role of Fe, Ca2+ and terminal mitochondrial electron transport. Kidney Int 51: 728–738, 1997
42. Zager RA, Johnson AC, Hanson SY, Lund S. Parenteral iron compounds sensitize mice to injury-initiated TNF-a mRNA production and TNF-a release. Am J Physiol Renal Physiol 288: F290–F297, 2005
43. Zhang DW, Saho J, Lin J, Zhang N, Lu BJ, Dong MQ, Han J. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332–336, 2009.